Novartis Ag (NVS) Net Margin (2009 - 2026)

Novartis Ag has disclosed Net Margin across 18 years of filings, most recently posting 22.65% for Q2 2026.

• In Q2 2026, Net Margin fell 610.0% year-over-year to 22.65%; the TTM figure through Jun 2026 stood at 32.73% (up 113.0% YoY), while the FY2025 annual figure was 25.64%, up 191.0% from the prior year.
• Net Margin came in at 22.65% for Q2 2026 at Novartis Ag, down from 34.48% in the prior quarter.
• In the past five years, Net Margin ranged from a high of 39.39% in Q4 2023 to a low of 13.25% in Q2 2022.
• Average Net Margin over 5 years is 27.47%, with a median of 28.03% recorded in 2024.
• Year-over-year, Net Margin tumbled 4789 bps in 2022 and surged 1651 bps in 2023.
• Over 5 years, Net Margin stood at 22.88% in 2022, then jumped by 72 bps to 39.39% in 2023, then decreased by 21 bps to 31.19% in 2024, then climbed by 20 bps to 37.54% in 2025, then tumbled by 40 bps to 22.65% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 22.65% in Q2 2026, 34.48% in Q1 2026, and 37.54% in Q4 2025.